Publications

Thompson M.G., Natarajan K., Irving S.A., Rowley E.A., Griggs E.P., Gaglani M., Klein N.P., Grannis S.J., DeSilva M.B., Stenehjem E., Reese S.E., Dickerson M., Naleway A.L., Han J., Konatham D., McEvoy C., Rao S., Dixon B.E., Dascomb K., Lewis N., Levy M.E., Patel P., Liao I.-C., Kharbanda A.B., Barron M.A., Fadel W.F., Grisel N., Goddard K., Yang D.-H., Wondimu M.H., Murthy K., Valvi N.R., Arndorfer J., Fireman B., Dunne M.M., Embi P., Azziz-Baumgartner E., Zerbo O., Bozio C.H., Reynolds S., Ferdinands J., Williams J., Link-Gelles R., Schrag S.J., Verani J.R., Ball S., and Ong T.C. (2022).

Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 States.

Sun H., Caporaso A., Cantor D., Davis T., and Blake K. (2022).

The effects of prompt interventions on web survey response rate and data quality measures.

Busch M.P., Stramer S.L., Stone M., Yu E.A., Grebe E., Notari E., Saa P., Ferg R., Molina Manrique I., Weil N., Fink R.V., Levy M.E., Green V., Cyrus S., Williamson P.C., Haynes J., Groves J., Krysztof D., Custer B., Kleinman S., Biggerstaff B.J., Opsomer J.D., and Jones J.M. (2022).

Population-weighted seroprevalence from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, vaccination, and hybrid immunity among US blood donations from January to December 2021.

Ren W., Krenzke T., West B.T., and Cantor D. (2022).

An evaluation of the quality of interviewer and virtual observations and their value for potential nonresponse bias reduction.

Graber J.E., Williams D., and Clark J. (2022).

Comparability of in-person and web screening: Does mode affect what households report?.

Madrigal J.M., Gunier R.B., Jones R.R., Flory A., Metayer C., Nuckols J.R., and Ward M.H. (2022).

Contributions of nearby agricultural insecticide applications to indoor residential exposures.

Roth S., Caporaso A., and DeMatteis J. (2022).

Variables appended to ABS frames: Has their data quality improved?.

Nelson A.T., Dybvik A., Mallinger P., McQuaid S.W., Watson D., Harney L.A., Stewart D.R., Dehner L.P., Messinger Y.H., Kunin-Batson A.S., and Schultz K.A.P. (2022).

Health-related quality of life in children and adolescents with pleuropulmonary blastoma: A report from the International PPB/DICER1 Registry.

Sugarbaker P.H. and Chang D. (2022).

Incomplete cytoreduction with peritoneal metastases from appendiceal mucinous neoplasms.

Anhang Price R., Quigley D.D., Hargraves J.L., Sorra J., Becerra-Ornelas A.U., Hays R.D., Cleary P.D., Brown J., and Elliott M.N. (2022).

A systematic review of strategies to enhance response rates and representativeness of patient experience surveys.

Casagrande S.S., Avilés-Santa M.L., Sotres-Alvarez D., Gallo L., Simon M., Kominiarek M., Talavera G., Stuebe A.M., Potter J., Perera M.J., Isasi C., Gonzalez J.S., Rust K., and Cowie C. (2022).

Association between gestational diabetes and 6-year incident diabetes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Paulin L.M., Halenar M.J., Edwards K.C., Lauten K., Stanton C.A., Taylor K., Hatsukami D., Hyland A., MacKenzie T., Mahoney M.C., Niaura R., Trinidad D., Blanco C., Compton W.M., Gardner L.D., Kimmel H.L., Lauterstein D., Marshall D., and Sargent J.D. (2022).

Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.

Gautam P., Sharma E., Li T., and Maziak W. (2022).

Prevalence and predictors of waterpipe smoking cessation among young adults in the US: Findings from a population-based study.

Gaglani M., Kim S.S., Naleway A.L., Levine M.Z., Edwards L., Murthy K., Dunnigan K., Zunie T., Groom H., Ball S., Jeddy Z., Hunt D., Wesley M.G., Sambhara S., Gangappa S., Grant L., Cao W., Liaini Gross F., Mishina M., Fry A.M., Thompson M.G., Dawood F.S., and Flannery B. (2022).

Effect of repeat vaccination on immunogenicity of quadrivalent cell-culture and recombinant influenza vaccines among healthcare personnel aged 18–64 Years: A randomized, open-label trial.

Williams R., Cao P., Li T., Luta G., Smith L., Mandelblatt J., Jeon J., Zhao A., Levy D., Davis K., Stanton C., Niaura R., Abrams D., Lobo T., Anderson E., Meza R., Jayasekera J., and Taylor K.L. (2022).

A randomized trial of telephone-based smoking cessation treatment in the lung cancer screening setting.

Yan T. and Tourangeau R. (2022).

Detecting underreporters of abortions and miscarriages in the National Study of Family Growth, 2011–2015.

Etemadi A., Buller I.D., Hashemian M., Roshandel G., Poustchi H., Espinosa M.M., Blount B.C., Pfeiffer C.M., Keshavarzi B., Flory A.R., Nasseri-Moghaddam S., Dawsey S.M., Freedman N.D., Abnet C.C., Malekzadeh R., and Ward M.H. (2022).

Urinary nitrate and sodium in a high-risk area for upper gastrointestinal cancers: Golestan Cohort Study.

Kumar V. and Encinosa W.E. (2022).

Revisiting the obesity paradox in healthcare expenditures among adults with diabetes.

Natarajan K., Prasad N., Dascomb K., Irving S.A., Yang D.-H., Gaglani M., Klein N.P., DeSilva M.B., Ong T.C., Grannis S.J., Stenehjem E., Link-Gelles R., Rowley E.A., Naleway A.L., Han J., Raiyani C., Benitez G.V., Rao S., Lewis N., Fadel W.F., Grisel N., Griggs E.P., Dunne M.M., Stockwell M.S., Mamawala M., McEvoy C., Barron M.A., Goddard K., Valvi N.R., Arndorfer J., Patel P., Mitchell P.K., Smith M., Kharbanda A.B., Fireman B., Embi P.J., Dickerson M., Davis J.M., Zerbo O., Dalton A.F., Wondimu M.H., Azziz-Baumgartner E., Bozio C.H., Reynolds S., Ferdinands J., Williams J., Schrag S.J., Verani J.R., Ball S., Thompson M.G., and Dixon B.E. (2022).

Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) vaccine dose against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults.

Klein N.P., Stockwell M.S., Demarco M., Gaglani M., Kharbanda A.B., Irving S.A., Rao S., Grannis S.J., Dascomb K., Murthy K., Rowley E.A., Dalton A.F., DeSilva M.B., Dixon B.E., Natarajan K., Stenehjem E., Naleway A.L., Lewis N., Ong T.C., Patel P., Konatham D., Embi P.J., Reese S.E., Grisel N., Goddard K., Barron M.A., Dickerson M., Liao I.-C., Fadel W.F., Yang D.-H., Arndorfer J., Fireman B., Griggs E.P., Valvi N.R., Hallowell C., Zerbo O., Reynolds S., Ferdinands J., Wondimu M.H., Williams J., Bozio C.H., Link-Gelles R., Azziz-Baumgartner E., Schrag S.J., Thompson M.G., and Verani J.R. (2022).

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5–17 years — VISION Network.

Kasza K.A., Tang Z., Xiao H., Marshall D., Stanton C., Gross A.L., Jackson K.M., Kelley D., Schroeder M.J., Vivar J.C., and Hyland A. (2022).

National longitudinal tobacco product cessation rates among US adults from the PATH Study: 2013–2019 (waves 1–5).

Campione J.R., Ritchie N.D., Fishbein H.A., Mardon R.E., Johnson M.C., Pace W., Birch R.J., Seeholzer E.L., Zhang X., Proia K., Siegel K.R., and McKeever Bullard K. (2022).

Use and impact of type 2 diabetes prevention interventions.

Link-Gelles R., Levy M.E., Gaglani M., Irving S.A., Stockwell M., Dascomb K., DeSilva M.B., Reese S.E., Liao I.-C., Ong T.C., Grannis S.J., McEvoy C., Patel P., Klein N.P., Hartmann E., Stenehjem E., Natarajan K., Naleway A.L., Murthy K., Rao S., Dixon B.E., Kharbanda A.B., Akinseye A., Dickerson M., Lewis N., Grisel N., Han J., Barron M.A., Fadel W.F., Dunne M.M., Goddard K., Arndorfer J., Konatham D., Valvi N.R., Currey J.C., Fireman B., Raiyani C., Zerbo O., Sloan-Aagard C., Ball S.W., Thompson M.G., and Tenforde M.W. (2022).

Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated — VISION Network, 10 States, December 2021–June 2022.

Slotman B.A., Stinchcomb D.G., Powell-Wiley T.M., Ostendorf D.M., Saelens B.E., Gorin A.A., Zenk S.N., and Berrigan D. (2022).

Environmental data and methods from the Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) core measures environmental working group.

Bardenheier B.H., Resnik L.J., Jutkowitz E., and Gravenstein S. (2022).

Patterns of limitation in physical function in late midlife associated with late-onset Alzheimer's disease and related dementias: A cluster analysis.

Tanski S., Halenar M.J., Edwards K.C., Emond J., Woloshin S., Brunette M., Schwartz L., Taylor K.A., Goniewicz M.L., Niaura R., Anic G., Chen Y., Callahan-Lyon P., Gardner L.D., Thekkudan T., Borek N., Kimmel H.L., Cummings K.M., Hyland A., and Sargent J. (2022).

Tobacco product use and functionally important respiratory symptoms among US adolescents/young adults.

Chaffee B.W., Lauten K., Sharma E., Everard C.D., Duffy K., Park-Lee E., Taylor E., Tolliver E., Watkins-Bryant T., Iafolla T., Compton W.M., Kimmel H.L., Hyland A., and Silveira M.L. (2022).

Oral health in the Population Assessment of Tobacco and Health Study.

Bond G.R., Al-Abdulmunem M., Drake R.E., Davis L.L., Meyer T., Gade D.M., Frueh B.C., Dickman R.B., and Ressler D.R. (2022).

Transition from military service: Mental health and well-being among service members and veterans with service-connected disabilities.

Stanton C.A., Tang Z., Sharma E., Seaman E., Gardner L.D., Silveira M.L., Hatsukami D., Day H.R., Cummings K.M., Goniewicz M.L., Limpert J., Everard C., Bansal-Travers M., Ambrose B., Kimmel H.L., Borek N., Compton W.M., Hyland A.J., and Pearson J.L. (2022).

Predictors of e-cigarette and cigarette use trajectory classes from early adolescence to emerging adulthood across four years (2013-2017) of the PATH Study.

Thompson H.R., Borger C., Paolicelli C., Whaley S.E., Reat A., and Ritchie L. (2022).

The relationship between breastfeeding and initial vegetable introduction with vegetable consumption in a national cohort of children ages 1-5 years from low-income households.

Mitchell P.K., Wang L., Stanhope B.J., Cronk B.D., Anderson R., Mohan S., Zhou L., Sanchez S., Bartlett P., Maddox C., DeShambo V., Mani R., Hengesbach L.M., Gresch S., Wright K., Mor S., Zhang S., Shen Z., Yan L., Mackey R., Franklin-Guild R., Zhang Y., Prarat M., Shiplett K., Ramachandran A., Narayanan S., Sanders J., Hunkapiller A.A., Lahmers K., Carbonello A.A., Aulik N., Lim A., Cooper J., Jones A., Guag J., Nemser S.M., Tyson G.H., Timme R., Strain E., Reimschuessel R., Ceric O., and Goodman L.B. (2022).

Multi-laboratory evaluation of the Illumina iSeq platform for whole genome sequencing of salmonella, escherichia coli and listeria.

Borger C., Paolicelli C., Sun B., Zimmerman T.P., and Dixit-Joshi S. (2022).

Duration of WIC participation and early feeding practices are associated with meeting the added sugars recommendation at age 3 years.

Borger C., Paolicelli C.P., and Sun B. (2022).

Duration of Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) participation is associated with children's diet quality at age 3 years.

Zebrak K., Yount N., Sorra J., Famolaro T., Gray L., Carpenter D., and Caporaso A. (2022).

Development, pilot study, and psychometric analysis of the AHRQ Surveys on Patient Safety Culture (SOPS) Workplace Safety Supplemental Items for Hospitals.

Cooper M., Day H.R., Ren C., Oniyide O., Corey C.G., Ambrose B.K., Cummings K.M., Sargent J., Niaura R., Pierce J.P., Kaufman A., Choi K., Goniewicz M.L., Stanton C.A., Villanti A., Kasza K., Bansal-Travers M., Silveira M.L., Kimmel H.L., Hull L.C., Koblitz A., Poonai K., Paredes A., Taylor K., Borek N., and Hyland A.J. (2022).

Correlates of tobacco product initiation among youth and young adults between waves 1–4 of the Population Assessment of Tobacco and Health (PATH) Study (2013–2018).

Borger C., Zimmerman T., DeMatteis J., Gollapudi B., Whaley S., Ritchie L., Au L., and May L. (2022).

WIC Infant and Toddler Feeding Practices Study-2: Fifth year report.

Josephson C.D., Glynn S., Mathew S., Birch R., Bakkour S., Baumann Kreuziger L., Busch M.P., Chapman K., Dinardo C., Hendrickson J., Hod E.A., Kelly S., Luban N., Mast A., Norris P., Custer B., Sabino E., Sachais B., Spencer B.R., Stone M., and Kleinman S. (2022).

The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.

Wipfli H.L., Kim M., Vassey J., and Stanton C. (2022).

Vaping and anime: A growing area of concern.

Bryan L.N., Smith-Grant J., Brener N., Kilmer G., Lo A., Queen B., and Underwood J.M. (2022).

Electronic versus paper and pencil survey administration mode comparison: 2019 Youth Risk Behavior Survey.

Chansky M.C., Price S.M., Aikin K.J., and O'Donoghue A.C. (2022).

Influence of data disclosures on physician decisions about off-label uses: Findings from a qualitative study.

Mahoney M.C., Rivard C., Kimmel H.L., Hammad H.T., Sharma E., Halenar M.J., Sargent J., Cummings K.M., Niaura R., Goniewicz M.L., Bansal-Travers M., Hatsukami D., Gaalema D., Fong G., Gravely S., Christensen C.H., Haskins R., Silveira M.L., Blanco C., Compton W., Stanton C.A., and Hyland A. (2022).

Cardiovascular outcomes among combustible-tobacco and electronic nicotine delivery system (ENDS) users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013-2019.

Jacob R.R., Korn A.R., Huang G.C., Easterling D., Gundersen D.A., Ramanadhan S., Vu T., Angier H., Brownson R.C., Haire-Joshu D., Oh A.Y., and Schnoll R. (2022).

Collaboration networks of the implementation science centers for cancer control: A social network analysis.

Harmon Q.E., Patchel S.A., Zhao S., Umbach D.M., Cooper T.E., and Baird D.D. (2022).

Depot medroxyprogesterone acetate use and the development and progression of uterine leiomyoma.

Chou W.-Y. S., Falisi A.L., Castro K., Ferrer R.A., Gaysynsky A., Huang G.C., Mollica M.A., Peterson E.B., and Kent E.E. (2022).

Cancer clinical trial providers’ perspectives on communicating goals of care: A key informant study.

Palmer J.E., Williams E., and Mennicke A. (2022).

Interpersonal violence experiences and disclosure patterns among lesbian, gay, bisexual, queer+, and heterosexual university students.

Porras C., Sampson J.N., Herrero R., Gail M.H., Cortés B., Hildesheim A., Cyr J., Romero B., Schiller J.T., Montero C., Pinto L.A., Schussler J., Coronado K., Sierra M.S., Kim J.J., Torres C.M., Carvajal L., Wagner S., Campos N.G., Ocampo R., Kemp T.J., Zuniga M., Lowy D.R., Avila C., Chanock S., Castrillo A., Estrada Y., Barrientos G., Monge C., Oconitrillo M.Y., and Kreimer A.R. (2022).

Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.

Roubinian N.H., Reese S.E., Qiao H., Plimier C., Fang F., Page G.P., Cable R.G., Custer B., Gladwin M.T., Goel R., Harris B., Hendrickson J.E., Kanias T., Kleinman S., Mast A.E., Sloan S.R., Spencer B.R., Spitalnik S.L., Busch M.P., and Hod E.A. (2022).

Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness.

Strong D.R., Leas E., Noble M., White M., Glasser A., Taylor K., Edwards K.C., Frissell K.C., Compton W.M., Conway K.P., Lambert E., Kimmel H.L., Silveira M.L., Hull L.C., van Bemmel D., Schroeder M.J., Cummings K.M., Hyland A., Feng J., Blount B., Wang L., and Niaura R. (2022).

Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study indicators of tobacco dependence using biomarkers of nicotine exposure across tobacco products.

McLaren J.L., Barnett E.R., Acquilano S.C., Concepcion Zayas M.T., Drake R.E., and Leyenaar J.K. (2022).

Psychotropic polypharmacy and antipsychotics in children: A survey of caregiver's perspectives.

Pogue J.A., Bond G.R., Drake R.E., Becker D.R., and Logsdon S.M. (2022).

Growth of IPS supported employment programs in the United States: An update.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
SiriusXM
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
Toyota
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2023 America's Best Mid-Size Employers Powered by Statista Forbes 2022 The Best Employers for Women Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.